A crucial part of WADA’s strategy is to develop partnerships with organizations that have the expertise to help find solutions, as well as having a vested interest in stopping the abuse of substances.
The pharmaceutical and biotechnology industries have acknowledged their interest and their growing commitment to help address the public health concern, to mitigate the misuse of their products and to combat doping in sport effectively.
Additional resources
-
Releases
WADA Emphasizes Importance of Cooperation with Pharmaceutical and Biotechnological Companies
-
Releases
WADA and Shionogi pharmaceutical company sign MOU formalizing collaboration to protect clean sport
-
Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth
Scientific Research
